Richard MacDonell

NARS as a candidate gene in dominant inherited peripheral neuropathies

Danique Beijer, Willem De Ridder, Tine Deconinck, Richard MacDonell, Wilson Marques, Peter De Jonghe, Stephan Zuchner, Rebecca Meyer-Schuman, Anthony Antonellis, Jonathan Baets

Conference Proceedings  |  2020  |  JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

A cross-sectional study of neuromuscular ultrasound in patients with chronic inflammatory demyelinating polyneuropathy (CIDP)

Nicholas Crump, Michael Cartwright, Richard MacDonell

Conference Proceedings  |  2020  |  JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Exploration of factors which influence treatment decisions of patients with Multiple Sclerosis

B Bardsley, JM Haynes, E Cinc, E Heriot, K-J Lazarus, M McMurtrie, RAL Macdonell

Conference Proceedings  |  2020  |  MULTIPLE SCLEROSIS JOURNAL

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation

Elham Khalilidehkordi, Laura Clarke, Simon Arnett, Wajih Bukhari, Sofia Jimenez Sanchez, Cullen O'Gorman, Jing Sun, Kerri M Prain, Mark Woodhall, Roger Silvestrini, Christine S Bundell, David Abernethy, Sandeep Bhuta, Stefan Blum, Mike Boggild, Karyn Boundy, Bruce J Brew, Matthew Brown, Wallace Brownlee, Helmut Butzkueven, et al.

Journal article  |  2020  |  Frontiers in Neurology

Neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) show overlap in their clinical features. We performed ..

Early clinical markers of aggressive multiple sclerosis

Charles B Malpas, Ali Manouchehrinia, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Guillermo Izquierdo, Sara Eichau, Roberto Bergamaschi, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Francois Grand'Maison, Serkan Ozakbas, Vincent Van Pesch, et al.

Journal article  |  2020  |  Brain

Patients with the ‘aggressive’ form of multiple sclerosis accrue disability at an accelerated rate, typically reaching Expanded Di..

Lymphocyte Levels Across Age Groups in Teriflunomide-treated Patients: Pooled Analysis from the Clinical Trials and the Real-World TERI-PRO Study

S Vukusic, J Oh, J De Seze, A Parajeles, Y Al Malik, RAL Macdonell, P Vermersch, EM Poole, Y Pyatkevich, A Miller

Conference Proceedings  |  2020  |  EUROPEAN JOURNAL OF NEUROLOGY

Safety and Effectiveness of Dimethyl Fumarate Maintained Over 4 Years in Multiple Sclerosis Patients Treated in Routine Medical Practice

Krupa Pandey, Kathryn Giles, Konstantin Balashov, Richard Macdonell, Jorg Windsheimer, Oksana Mokliatchouk, Becky Parks, Filipe Branco, Cynthia C Jones

Conference Proceedings  |  2020  |  NEUROLOGY

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

Giancarlo Comi, Raed Alroughani, Aaron L Boster, Ann D Bass, Regina Berkovich, Oscar Fernandez, Ho Jin Kim, Volker Limmroth, Jan Lycke, Richard AL Macdonell, Basil Sharrack, Barry A Singer, Patrick Vermersch, Heinz Wiendl, Tjalf Ziemssen, Alan Jacobs, Nadia Daizadeh, Claudio E Rodriguez, Anthony Traboulsee

Journal article  |  2019  |  Multiple Sclerosis Journal

BACKGROUND: Alemtuzumab is given as two annual courses. Patients with continued disease activity may receive as-needed additional ..

Alemtuzumab improves disability and quality of life outcomes over 8 years in patients with RRMS

H Wiendl, RA Aburashed, R Alroughani, A Boster, A Chan, D Dive, S Eichau, D Kantor, HJ Kim, C LaGanke, J Lycke, RAL Macdonell, C Pozzilli, TF Scott, P Vermersch, Z Choudhry, N Daizadeh, DP Baker, S Hunter

Conference Proceedings  |  2019  |  MULTIPLE SCLEROSIS JOURNAL

Exploration of factors which influence treatment decisions of patients with multiple sclerosis

B Bardsley, JM Haynes, E Cinc, E Heriot, K-J Lazarus, M McMurtrie, RAL Macdonell

Conference Proceedings  |  2019  |  MULTIPLE SCLEROSIS JOURNAL